Buy molnunat 200 mg (Molnupiravir) – 40 Tablets

SKU : Molnupiravir 200

Medsloop shopping offers

Get discount on order above $200 . discount upto 20%

Coupone : ML20

Free Shipping

On order above $150

Doorstep Delivery

10 to 15 days

FDA Approved Drugs

Sale FDA approved drugs


Each capsule of molnunat 200 mg contains of Molnupiravir and comes 40 capsules per bottle. It is used to treat COVID-19 infected by SAR-CoV-2.

Payment Method :

Filters Sort results
Reset Apply
Pack size
Add to cart
Molnudac by (Zydus) -40 tablet
Min: 1
Step: 1
Molnunat by (Natco) -40 tablet
Min: 1
Step: 1
GTIN: Molnupiravir 200 SKU Molnupiravir 200 Category Tags , , ,

Guaranteed SAFE Checkout

safe checkout

Molnupiravir Information

What is this drug used for?

  • It is used to treat COVID-19 in those infected by SARS-CoV-2.

Adverse Effects


  • Diarrhea (2%)
  • Nausea (1%)
  • Dizziness (1%)


  • Selected Grade 3 and 4 laboratory abnormalities in chemistry (ALT, AST, creatinine, and lipase) and hematology (hemoglobin, platelets, and leukocytes)


  • There are limited clinical data available; serious and unexpected adverse events may occur that have yet to be reported.
  • May cause fetal harm when administered to pregnant females.

Bone and cartilage toxicity

  • Not authorised for use in patients aged <18 years owing to possible effects on bone and cartilage growth
  • Bone and cartilage toxicity was observed in rats after repeated dosing
  • Safety and efficacy have not been established in pediatric patients


  • Not recommended during pregnancy

Dosage Modifications

Renal impairment

  • Mild or moderate (eGFR >30 mL/min): No dosage adjustment necessary
  • Severe (eGFR <30 mL/min), end-stage renal disease, or patients on dialysis: Pharmacokinetics not evaluated; not expected to have a significant effect on NHC (N4-hydroxycytidine) exposure

Hepatic impairment

  • Mild to severe (Child-Pugh Class A to C): No dosage adjustment required
  • Preclinical data indicate that hepatic elimination is not expected to be a major route of NHC elimination

Dosing Considerations

Verify pregnancy status in females of childbearing potential before initiating

Limitations of use

  • Not authorised for use in patients aged <18 years
  • Not authorised for initiation of treatment in patients requiring hospitalization owing to COVID-19
  • Not authorised for use for >5 consecutive days
  • Not authorised for preexposure or postexposure prophylaxis for prevention of COVID-19


Oral Administration

Take orally, with or without food

Missed dose

  • <10 hours: Take missed dose as soon as possible, and resume normal dosing schedule
  • >10 hours: Skip dose, and take the next dose at the regularly scheduled time
  • Do not double dose to make up for missed dose


Store at 20-25ºC (68-77ºF); excursions permitted to 15-30ºC (59-86ºF)

There are no reviews yet.

Be the first to review “Buy molnunat 200 mg (Molnupiravir) – 40 Tablets”

You cannot copy content of this page